Hematologic complications of rheumatic disease therapies.

Abstract

Hematologic side effects of rheumatic disease therapies are generally mild and reversible; however, the clinician must be alert for potential profound and life-threatening toxicities. A knowledge of the toxicity patterns for the individual drugs is necessary to anticipate potential complications. Management of acute leukemias and lymphomas arising in… (More)

Topics

  • Presentations referencing similar topics